Highlights from Day 2 of the AAO Congress

Article

New roles for the femtosecond discussed. Subretinal implant disappoints. Genentech defends its actions relating to Avastin decision. Glaucoma pipeline looks very healthy, and much more.

Related Videos
At this year's ESCRS meeting, we asked presenters and attendees, 'What do yoou wish you'd known earlier in your ophthalmology career?'
Diana Do, MD, Professor of Ophthalmology, Byers Eye Institute, Stanford University, discusses the PHOTON study results as presented AAO
Penny A Asbell, MD, FACS speaks at the 2023 AAO meeting
Related Content
A crowd listens to a speaker at a conference. Image credit: ©Bojan – stock.adobe.com

AAO 2023 brings data, diagnostics and digital workflows to the forefront

December 8th 2023
Article

Experts from around the globe converged in San Francisco, California

Site Logo

Novel Therapies in Neovascular AMD and DME: Achieving Superior Anatomic Outcomes with Fewer Injections

June 29th 2023
Podcast
A physician uses a stylus to look at the image of a cornea. Image credit: ©warloka79 – stock.adobe.com

Why the future of ophthalmology is in corneal grafts

December 6th 2023
Article

Restoration and regeneration represent a new paradigm

Long-Term Efficacy and Durability of Latest Therapies in neovascular AMD and DMO

Long-Term Efficacy and Durability of Latest Therapies in neovascular AMD and DMO

December 19th 2022
Podcast
An optometrist examines an elderly patient's eyes. Image credit: ©Nadia L/peopleimages.com – stock.adobe.com

Prevent Blindness participates in first-ever World Geographic Atrophy Day

December 5th 2023
Article

In recognition of global Geographic Atrophy Week, Prevent Blindness is providing free educational resources on GA for patients, care partners and healthcare professionals

How to SMILE with a challenging patient – Reaping the speed of the VISUMAX 800 femtosecond laser

How to SMILE with a challenging patient – Reaping the speed of the VISUMAX 800 femtosecond laser

December 4th 2023
Article
© 2023 MJH Life Sciences

All rights reserved.